Trade Amgen ^AMGN

Why Amgen Inc. (AMGN) is One of the Best Stem Cell Therapy Stocks to Buy

Vanguard Group Inc. Raises Stock Position in Amgen Inc. $AMGN

Munich Reinsurance Co Stock Corp in Munich Has $1.14 Million Holdings in Amgen Inc. $AMGN

A Look At Amgen (AMGN) Valuation As New AI Focused Leadership Team Takes Shape

Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts

Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC

5 Best Stem Cell Therapy Stocks to Buy

Amgen Inc. $AMGN Stock Holdings Boosted by Marathon Capital Management - Daily Political

Wall Street Zen Downgrades Amgen (NASDAQ:AMGN) to Hold

Editorial | Influx of global firms underscores Hong Kong's economic recovery

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS | Morningstar

Directional Asset Management Invests $2.41 Million in Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN is China Universal Asset Management Co. Ltd.'s 9th Largest Position

Amgen Inc. $AMGN Shares Sold by Arizona State Retirement System

Directional Asset Management Makes New $2.41 Million Investment in Amgen Inc. $AMGN - Stock Observer

Amgen Inc. $AMGN Position Lessened by OLD National Bancorp IN - Daily Political

Amgen Insiders Sell US$4.1m Of Stock, Possibly Signalling Caution

Amgen Inc. $AMGN Shares Sold by M&T Bank Corp

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Trims Position in Amgen Inc. $AMGN - Stock Observer

Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead of Earnings

Amgen (AMGN) to Release Earnings on Thursday

Torray Investment Partners LLC Sells 7,883 Shares of Amgen Inc. $AMGN - Daily Political

Amgen (NASDAQ:AMGN) Stock Acquired Rep. Maria Elvira Salazar

The Bull Case For Amgen (AMGN) Could Change Following Strong Q4 Beat And Upbeat 2026 Guidance

Amgen Inc. $AMGN Shares Bought by KLP Kapitalforvaltning AS

10 Most Undervalued Dow Stocks to Buy Now

Ex-Amgen Worker Files Suit Over Health Plan Tobacco Use Penalty

AMGN Initiated Coverage by Canaccord Genuity -- Rating Set to Ho

Amgen Inc. $AMGN Shares Sold by Northern Financial Advisors Inc - Markets Daily

Ticino Wealth Invests $2.54 Million in Amgen Inc. $AMGN

Jones Kertz & Associates Inc. Purchases Shares of 14,070 Amgen Inc. $AMGN - Markets Daily

Novem Group Raises Holdings in Amgen Inc. $AMGN

Amgen Inc. $AMGN Stake Decreased by PFG Advisors

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

What to Expect From Amgen's Next Quarterly Earnings Report

Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source

TD Waterhouse Canada Inc. Increases Holdings in Amgen Inc. $AMGN - Daily Political

Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy

Will Amgen's Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative?

Is It Too Late To Consider Amgen (AMGN) After A 32% One-Year Share Price Rally?

Patriot Financial Group Insurance Agency LLC Has $638,000 Stock Holdings in Amgen Inc. $AMGN - Daily Political

Oak Harvest Investment Services Reduces Stake in Amgen Inc. $AMGN - Stock Observer

GF Fund Management CO. LTD. Boosts Position in Amgen Inc. $AMGN - Stock Observer

2 S&P 500 Stocks Worth Your Attention and 1 We Ignore

UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400

OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration

Assessing Whether Amgen (AMGN) Still Looks Undervalued After Recent Share Price Pullback

Argo Wealth Advisory LLC Purchases New Shares in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Whittier Trust Co. - Daily Political

2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds

OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios)

KBC Group NV Has $187.27 Million Stock Holdings in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Acquired by Lbp Am Sa

Amgen Inc. $AMGN Shares Bought by Cwm LLC | MarketBeat

Amgen Inc. $AMGN Shares Purchased by Farther Finance Advisors LLC

Amgen Inc. $AMGN Holdings Raised by Lbp Am Sa - Stock Observer

Amgen Inc. $AMGN Shares Bought by Cornerstone Wealth Group LLC - Stock Observer

5 Healthcare Stocks with Highest Dividends

Third View Private Wealth LLC Acquires New Shares in Amgen Inc. $AMGN - Markets Daily

Third View Private Wealth LLC Makes New $482,000 Investment in Amgen Inc. $AMGN - Stock Observer

Foster Victor Wealth Advisors LLC Acquires 1,541 Shares of Amgen Inc. $AMGN - Daily Political

Uplizna Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035

Amgen And Zai Lab DLL3 Alliance Adds New Dimension To Oncology Story

Assetmark Inc. Buys 14,341 Shares of Amgen Inc. $AMGN

Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen

Other news to note for April 14, 2026 | BioWorld

Smith Moore & CO. Sells 1,706 Shares of Amgen Inc. $AMGN - Daily Political

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer

Amgen (NASDAQ:AMGN) Price Target Raised to $400.00

Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength

Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After New Lung Cancer Trial Progress And Amgen Collaboration

Amgen (NASDAQ:AMGN) Raised to "Buy" at Wall Street Zen - Stock Observer

Curtis Advisory Group LLC Makes New Investment in Amgen Inc. $AMGN

KG&L Capital Management LLC Lowers Stock Position in Amgen Inc. $AMGN - Stock Observer

Amgen (NASDAQ:AMGN) Price Target Raised to $351.00 - Markets Daily

Assessing Amgen (AMGN) Valuation As TEPEZZA And MariTide Trial Results Draw Fresh Investor Focus

Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)

Amgen (NASDAQ:AMGN) Price Target Raised to $326.00

Amgen's Tarlatamab Receives Approval for Lung Cancer Treatment in China, ETPharma

Prime Capital Investment Advisors LLC Has $6.32 Million Stake in Amgen Inc. $AMGN - Markets Daily

Amgen's lung cancer drug tarlatamab wins China approval